Evidence map›Paper›PMID 42877941›Full record

ReviewTaiwan journal of ophthalmology

Diagnosis and management of giant cell arteritis.

Laura Bonelli, Anthony C Arnold

Abstract readReview
In one paragraph

Review in Taiwan journal of ophthalmology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Laura BonelliStein Eye Institute, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
Anthony C ArnoldStein Eye Institute, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Giant cell arteritis (GCA) is the most common form of vasculitis affecting patients above the age of 50. Over the past few decades, our understanding of the pathophysiology, clinical presentation, and treatment of the disease has increased tremendously. We now recognize that there is more than just the compromise of the temporal artery and its branches. Advances in technology and immunology have led to new diagnostic imaging methods and more targeted treatments with fewer side effects. The aim of this review is to summarize the advances in the presentation, diagnosis, and treatment of GCA.

Indexed as

Giant cell arteritisgiant cell arteritis treatmentlaboratory testingtemporal artery ultrasound

Identifiers

PMID42877941
PMCPMC13668189

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.